J3455

JZL 184 hydrate

≥97% (HPLC), monoacylglycerol lipase inhibitor, powder

• Synonym(e): JZL184 hydrate
• Empirische Formel (Hill-System): C₂₇H₂₄N₂O₉ · xH₂O
• CAS-Nummer: 1101854-58-3
• Molekulargewicht: 520.49 (anhydrous basis)
• UNSPSC Code: 12352200
• PubChem Substance ID: 329815406
• NACRES: NA.77
• MDL number: MFCD12912421
• Assay: ≥97% (HPLC)
• Form: powder
• Quality level: 100

Eigenschaften

• Produktname: JZL 184 hydrate, ≥97% (HPLC)
• SMILES string: O.OC(C1CCN(CC1)C(=O)Oc2ccc(cc2)[N+]([O-])=O)(c3ccc4OCOc4c3)c5ccc6OCOc6c5
• InChI: 1S/C27H24N2O9.H2O/c30-26(38-21-5-3-20(4-6-21)29(32)33)28-11-9-17(10-12-28)27(31,18-1-7-22-24(13-18)36-15-34-22)19-2-8-23-25(14-19)37-16-35-23;/h1-8,13-14,17,31H,9-12,15-16H2;1H2
• InChI key: HNSBVGMOKGQJLT-UHFFFAOYSA-N
• assay: ≥97% (HPLC)
• form: powder
• color: , White to green-yellow to yellow
• solubility: DMSO: >20 mg/mL
• storage temp.: 2-8°C
• Quality Level: 100

Beschreibung

Application

JZL 184 hydrate has been used as an inhibitor of monoacylglycerol lipase to study its effect on human osteoblast differentiation and proliferation[1] and postsynaptic neurons.[2]

Biochem/physiol Actions

JZL184 selectively inhibits MAGL, the enzyme predominantly responsible for the degradation of the endocannabinoid 2-arachidonoylglycerol (2-AG).

JZL184 selectively inhibits MAGL, the enzyme predominantly responsible for the degradation of the endocannabinoid 2-arachidonoylglycerol (2-AG). Anandamide and 2-AG are the two endogenous endocannabinoids that activate the cannabinoid receptors CB1 and CB2. Anandamide is predominantly metabolized by fatty acid amide hydrolase (FAAH), whereas monoacylglycerol lipase (MAGL) is thought to be the enzyme primarily responsible for the degradation of 2-AG. It is difficult to separate the activities of the two because most currently available inhibitors of MAGL are not selective, and also inhibit FAAH or other enzymes. JZL 184 is the first selective inhibitor of MAGL with nanomolar portency and over 200-fold selectivity for MAGL vs FAAH. When administered to mice, JZL184 increased levels of 2-arachidonoylglycerol in the brain by about 8-fold, with no effect on levels of anandamide.

Features and Benefits

This compound is featured on the Cannabinoid Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

Sicherheitshinweise

• pictograms: GHS06
• signalword: Danger
• hcodes: H301
• pcodes: P264 - P270 - P301 + P310 - P405 - P501
• Hazard Classifications: Acute Tox. 3 Oral
• Lagerklasse: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable